Lateral Flow Assay Market Synopsis:

Lateral Flow Assay Market Size Was Valued at USD 5.8 Billion in 2023, and is Projected to Reach USD 29.82 Billion by 2032, Growing at a CAGR of 4.90% From 2024-2032.

Lateral Flow Assay (LFA) market is defined as the field associated with the creation and supply of portable diagnostic devices that use lateral flow processes for the identification of target biomolecules, antibodies, or pathogens in assorted matrices. These assays have all become popular because they are easy to perform, fast and compact in size thus being indispensable in areas like clinical diagnosis, animal disease diagnosis, checking of food quality and inspection of the environment.

The Lateral Flow Assay market has experienced remarkable growth within the last few years, particularly for applications in healthcare and other important industries. The advantage of using LFAs is that the test procedure is simple and the results can be easily interpreted without the complexity of using some of the sophisticated laboratory equipment. Due to their simplicity they have been adopted widely in point of care testing especially if in a center with little or no technology. The novel coronavirus still pushed people to embrace LFAs more because rapid antigen tests were vital for community testing. The possibilities of multiplexing, modifications of assays and materials, increasing sensitivity and specificity have been recently observed in the market.

Besides the use in healthcare sector, the Lateral Flow Assay market also comprises of veterinary diagnostics and applications, food security and environmental analysis. Veterinary diagnostics use LFAs in identification of diseases affecting livestock and pets as a way of managing the spread of the diseases and for effective animal health. In food safety, LFAs used in determination of contaminant, allergens and pathogen hence protecting consumers from the dangerous foods. In environmental testing utility, LFAs are also applicable in such cases involving inspection of pollutants and pathogen presence in diverse ecosystems. Its broad use spectrum helps to enhance and make the market stronger due to continuous research with the objective of enhancing the assay performance and increasing its usability in different sectors.

Lateral Flow Assay Market

Lateral Flow Assay Market Trend Analysis:

Increasing Demand for Rapid Testing Solutions

  • Market trend that can be observed in the Lateral Flow Assay is the constantly rising demand for the rapid tests since this pattern stimulates improved diagnosis and treatment services in healthcare sector. The COVID-19 pandemic itself raised concerns over the fast and efficient detection methods making the basis for the enhancement of LFA-based tests. This is not confined to communicable illnesses; it applies to different fields, which include recurrent conditions, and wellness. This is again due to the fact that the LFAs give the user an immediate result in minutes, which fits into the new trend in the healthcare industry, time is of the essence.
  • Furthermore, increased development in technology has improved the functioning of lateral flow assays, increasing their reliability and ease of use. New features consisting of nanomaterials and digital readout are extending LFAs past their previous qualitative roles to become quantitative assays with better precision. Decentralized and centralised demand for rapid tests that can be run away from a laboratory is on the rise, hence lateral flow assays will also thrive in the future and drive the market.

Expansion in Emerging Markets

  • A remarkable characteristic of the Lateral Flow Assay industry is that there remains vast potential for growth in new markets. As a result, the population of these regions receives better medical care and improves infrastructure, the necessity of affordable and available diagnostic devices is increasing. These markets are well suited to lateral flow assays because of their low cost and simple usage. Government plans to invest more-money to expand and enhance the distribution of Healthcare services in the emerging and remote areas increases the prospects for LFAs. This suggests that firms can benefit from the opportunity to localize some of the products such as realizing the need to develop some of the assays relevant to the region, and foster partnership with local distributors so as to improve on market access.
  • Also, the increasing concern with disease control and health management in new economies is a favorable condition for LFAs. If people tend to pay attention to their health and try to receive a correct and timely diagnosis, lateral flow assays can be useful for the tasks of the corresponding strategies. This increases the market opportunities for variety and differentiation of manufactur for LFAs for non-communicable diseases and chronic illnesses. The second potential benefit relates to the strategic position that companies capture the increasing clientele in emerging markets thus increasing revenues and geographical coverage.

Lateral Flow Assay Market Segment Analysis:

Lateral Flow Assay Market is Segmented on the basis of type, Technique, Sample Type, Application, End User, and Region

By Type, Kits & Reagents segment is expected to dominate the market during the forecast period

  • The Lateral Flow Assay market is segmented into two primary categories: Kits & Reagents is a type of testing product, and Lateral Flow Readers is a kind of instrument in this testing industry. Kits & Reagents are undeniably the largest category in the market as they are required to perform lateral flow tests and contain the material required for the sample preparation process. They are believed to comprise one or many assays, each of which is intended for use in a given context, from clinical diagnostics to food analysis. The rise is being attributed to a growth in the use of point-of-care devices for testing due to the growing preference for such kits and devices among physicians and consumers.
  • On the other hand, Lateral Flow Readers are emerging in the market because they improving the test procedure of interpreting results. These devices provide readouts in digital format with higher precision, accuracy and reproducibility than in lateral flow assays. With the growth of the concept of automation and digitization in the healthcare sector, lateral flow readers are expected to serve as dominant enabling elements regarding the increased application of the lateral flow assays in different fields, in turn, driving the market.

By Application, Clinical Testing segment expected to held the largest share

  • Depending on applications, Lateral Flow Assay market has been segmented as Clinical Testing, Veterinary Diagnostics, Food Safety & Environmental Testing and Drug Development & Quality Testing. Clinical testing is the largest application area due to increasing demands for fast and accurate diagnostic tools in patient care. New infections and the shift towards minimally invasive procedures have expanded the use of lateral flow assays to hospitals, clinics and home usage.
  • Another significant growth area is in veterinary diagnostics because individuals both with pets and livestock are increasingly keen on early diagnosis of diseases and treatment. Lateral flow assays become useful veterinary tools to help in animal health surveillance and disease management. Additionally, there is increased demand in food safety and environmental testing application due to increasing regulation standards and knowledge of food borne illnesses. Since time-sensitive development of lateral flow assays brings its high efficiency in detecting the safety standards in these sectors and therefore the overall expansion of the lateral flow assay market.

Lateral Flow Assay Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

  • North America is expected to have the largest share in the Lateral Flow Assay market as the health care sector develops, there is an enhanced spending in the research and development processes, and there has been a rise in the chronic diseases in the region. Implementation of strong regulatory systems in combination with relevant market participants contributes to the accelerated growth and commercialization of the lateral flow assays in the analyzed region. Even more so, the United States remains one of the leaders in adopting rapid diagnostic technologies, as more attention is paid to the faster and easier diagnostics as a means to better patient outcome.
  • However, the increasing number of COVID-19 cases in North America has fuelled more expansion of the lateral flow assay market. The massive requirement for quick solutions compelled the utilization of lateral flow assays for COVID-19 examination, which initiated an enormous impact towards the progression of the market. Given the ongoing emphasis of healthcare providers on developing fast tests for various uses, diagnostica is set to increase further, confirming North Americai as the leading regional market for lateral flow assay.

Active Key Players in the Lateral Flow Assay Market:

  • Abbott Laboratories (USA)
  • Roche Diagnostics (Switzerland)
  • Quidel Corporation (USA)
  • Siemens Healthineers (Germany)
  • BD (Becton, Dickinson and Company) (USA)
  • bioMérieux (France)
  • Hologic, Inc. (USA)
  • Meridian Bioscience, Inc. (USA)
  • PerkinElmer, Inc. (USA)
  • Medline Industries, Inc. (USA)
  • Danaher Corporation (USA)
  • Agilent Technologies (USA)
  • Other Active Players

Lateral Flow Assay Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 5.8 Billion

Forecast Period 2024-32 CAGR:

4.90%

Market Size in 2032:

USD 29.82 Billion

 

By Type

  • Kits & Reagents
  • Lateral Flow Readers

Segments Covered:

By Technique

  • Sandwich Assays
  • Competitive Assays
  • Multiplex Detection Assays

By Sample Type

  • Blood Samples
  • Urine Samples
  • Saliva Samples

By Application

  • Clinical Testing
  • Veterinary Diagnostics
  • Food Safety & Environmental Testing
  • Drug Development & Quality Testing

By End User

  • Hospitals & Clinics
  • Diagnostics Laboratories
  • Home Care Settings
  • Pharmaceuticals & Biotechnology Companies
  • Others

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Technological Advancements

Key Market Restraints:

  • Competition from Alternative Testing Methods

Key Opportunities:

  • Expansion in Emerging Markets

Companies Covered in the report:

  • Abbott Laboratories (USA), Roche Diagnostics (Switzerland), Quidel Corporation (USA), Siemens Healthineers (Germany), BD (Becton, Dickinson and Company) (USA), bioMérieux (France), Hologic, Inc. (USA), Meridian Bioscience, Inc. (USA), PerkinElmer, Inc. (USA) and Other Active Players.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Lateral Flow Assay Market by Technique
 4.1 Lateral Flow Assay Market Snapshot and Growth Engine
 4.2 Lateral Flow Assay Market Overview
 4.3 Sandwich Assays
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Sandwich Assays: Geographic Segmentation Analysis
 4.4 Competitive Assays
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Competitive Assays: Geographic Segmentation Analysis
 4.5 Multiplex Detection Assays)
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Multiplex Detection Assays): Geographic Segmentation Analysis
 4.6 Sample Type(Blood Samples
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Sample Type(Blood Samples: Geographic Segmentation Analysis
 4.7 Urine Samples
  4.7.1 Introduction and Market Overview
  4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.7.3 Key Market Trends, Growth Factors and Opportunities
  4.7.4 Urine Samples: Geographic Segmentation Analysis
 4.8 Saliva Samples
  4.8.1 Introduction and Market Overview
  4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.8.3 Key Market Trends, Growth Factors and Opportunities
  4.8.4 Saliva Samples: Geographic Segmentation Analysis
 4.9 Others
  4.9.1 Introduction and Market Overview
  4.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.9.3 Key Market Trends, Growth Factors and Opportunities
  4.9.4 Others: Geographic Segmentation Analysis

Chapter 5: Lateral Flow Assay Market by Type
 5.1 Lateral Flow Assay Market Snapshot and Growth Engine
 5.2 Lateral Flow Assay Market Overview
 5.3 Kits & Reagents
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Kits & Reagents: Geographic Segmentation Analysis
 5.4 Lateral Flow Readers
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Lateral Flow Readers: Geographic Segmentation Analysis

Chapter 6: Lateral Flow Assay Market by Application
 6.1 Lateral Flow Assay Market Snapshot and Growth Engine
 6.2 Lateral Flow Assay Market Overview
 6.3 Clinical Testing
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Clinical Testing: Geographic Segmentation Analysis
 6.4 Veterinary Diagnostics
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Veterinary Diagnostics: Geographic Segmentation Analysis
 6.5 Food Safety & Environmental Testing
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Food Safety & Environmental Testing: Geographic Segmentation Analysis
 6.6 Drug Development & Quality Testing
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Drug Development & Quality Testing: Geographic Segmentation Analysis

Chapter 7: Lateral Flow Assay Market by End User
 7.1 Lateral Flow Assay Market Snapshot and Growth Engine
 7.2 Lateral Flow Assay Market Overview
 7.3 Hospitals & Clinics
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Hospitals & Clinics: Geographic Segmentation Analysis
 7.4 Diagnostics Laboratories
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Diagnostics Laboratories: Geographic Segmentation Analysis
 7.5 Home Care Settings
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Home Care Settings: Geographic Segmentation Analysis
 7.6 Pharmaceuticals & Biotechnology Companies
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Pharmaceuticals & Biotechnology Companies: Geographic Segmentation Analysis
 7.7 Others
  7.7.1 Introduction and Market Overview
  7.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.7.3 Key Market Trends, Growth Factors and Opportunities
  7.7.4 Others: Geographic Segmentation Analysis

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Benchmarking
  8.1.2 Lateral Flow Assay Market Share by Manufacturer (2023)
  8.1.3 Industry BCG Matrix
  8.1.4 Heat Map Analysis
  8.1.5 Mergers and Acquisitions  
 8.2 ABBOTT LABORATORIES (USA)
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Role of the Company in the Market
  8.2.5 Sustainability and Social Responsibility
  8.2.6 Operating Business Segments
  8.2.7 Product Portfolio
  8.2.8 Business Performance
  8.2.9 Key Strategic Moves and Recent Developments
  8.2.10 SWOT Analysis
 8.3 ROCHE DIAGNOSTICS (SWITZERLAND)
 8.4 QUIDEL CORPORATION (USA)
 8.5 SIEMENS HEALTHINEERS (GERMANY)
 8.6 BD (BECTON
 8.7 DICKINSON AND COMPANY) (USA)
 8.8 BIOMÉRIEUX (FRANCE)
 8.9 HOLOGIC INC. (USA)
 8.10 MERIDIAN BIOSCIENCE INC. (USA)
 8.11 PERKINELMER INC. (USA)
 8.12 OTHER ACTIVE PLAYERS

Chapter 9: Global Lateral Flow Assay Market By Region
 9.1 Overview
 9.2. North America Lateral Flow Assay Market
  9.2.1 Key Market Trends, Growth Factors and Opportunities
  9.2.2 Top Key Companies
  9.2.3 Historic and Forecasted Market Size by Segments
  9.2.4 Historic and Forecasted Market Size By Technique
  9.2.4.1 Sandwich Assays
  9.2.4.2 Competitive Assays
  9.2.4.3 Multiplex Detection Assays)
  9.2.4.4 Sample Type(Blood Samples
  9.2.4.5 Urine Samples
  9.2.4.6 Saliva Samples
  9.2.4.7 Others
  9.2.5 Historic and Forecasted Market Size By Type
  9.2.5.1 Kits & Reagents
  9.2.5.2 Lateral Flow Readers
  9.2.6 Historic and Forecasted Market Size By Application
  9.2.6.1 Clinical Testing
  9.2.6.2 Veterinary Diagnostics
  9.2.6.3 Food Safety & Environmental Testing
  9.2.6.4 Drug Development & Quality Testing
  9.2.7 Historic and Forecasted Market Size By End User
  9.2.7.1 Hospitals & Clinics
  9.2.7.2 Diagnostics Laboratories
  9.2.7.3 Home Care Settings
  9.2.7.4 Pharmaceuticals & Biotechnology Companies
  9.2.7.5 Others
  9.2.8 Historic and Forecast Market Size by Country
  9.2.8.1 US
  9.2.8.2 Canada
  9.2.8.3 Mexico
 9.3. Eastern Europe Lateral Flow Assay Market
  9.3.1 Key Market Trends, Growth Factors and Opportunities
  9.3.2 Top Key Companies
  9.3.3 Historic and Forecasted Market Size by Segments
  9.3.4 Historic and Forecasted Market Size By Technique
  9.3.4.1 Sandwich Assays
  9.3.4.2 Competitive Assays
  9.3.4.3 Multiplex Detection Assays)
  9.3.4.4 Sample Type(Blood Samples
  9.3.4.5 Urine Samples
  9.3.4.6 Saliva Samples
  9.3.4.7 Others
  9.3.5 Historic and Forecasted Market Size By Type
  9.3.5.1 Kits & Reagents
  9.3.5.2 Lateral Flow Readers
  9.3.6 Historic and Forecasted Market Size By Application
  9.3.6.1 Clinical Testing
  9.3.6.2 Veterinary Diagnostics
  9.3.6.3 Food Safety & Environmental Testing
  9.3.6.4 Drug Development & Quality Testing
  9.3.7 Historic and Forecasted Market Size By End User
  9.3.7.1 Hospitals & Clinics
  9.3.7.2 Diagnostics Laboratories
  9.3.7.3 Home Care Settings
  9.3.7.4 Pharmaceuticals & Biotechnology Companies
  9.3.7.5 Others
  9.3.8 Historic and Forecast Market Size by Country
  9.3.8.1 Russia
  9.3.8.2 Bulgaria
  9.3.8.3 The Czech Republic
  9.3.8.4 Hungary
  9.3.8.5 Poland
  9.3.8.6 Romania
  9.3.8.7 Rest of Eastern Europe
 9.4. Western Europe Lateral Flow Assay Market
  9.4.1 Key Market Trends, Growth Factors and Opportunities
  9.4.2 Top Key Companies
  9.4.3 Historic and Forecasted Market Size by Segments
  9.4.4 Historic and Forecasted Market Size By Technique
  9.4.4.1 Sandwich Assays
  9.4.4.2 Competitive Assays
  9.4.4.3 Multiplex Detection Assays)
  9.4.4.4 Sample Type(Blood Samples
  9.4.4.5 Urine Samples
  9.4.4.6 Saliva Samples
  9.4.4.7 Others
  9.4.5 Historic and Forecasted Market Size By Type
  9.4.5.1 Kits & Reagents
  9.4.5.2 Lateral Flow Readers
  9.4.6 Historic and Forecasted Market Size By Application
  9.4.6.1 Clinical Testing
  9.4.6.2 Veterinary Diagnostics
  9.4.6.3 Food Safety & Environmental Testing
  9.4.6.4 Drug Development & Quality Testing
  9.4.7 Historic and Forecasted Market Size By End User
  9.4.7.1 Hospitals & Clinics
  9.4.7.2 Diagnostics Laboratories
  9.4.7.3 Home Care Settings
  9.4.7.4 Pharmaceuticals & Biotechnology Companies
  9.4.7.5 Others
  9.4.8 Historic and Forecast Market Size by Country
  9.4.8.1 Germany
  9.4.8.2 UK
  9.4.8.3 France
  9.4.8.4 The Netherlands
  9.4.8.5 Italy
  9.4.8.6 Spain
  9.4.8.7 Rest of Western Europe
 9.5. Asia Pacific Lateral Flow Assay Market
  9.5.1 Key Market Trends, Growth Factors and Opportunities
  9.5.2 Top Key Companies
  9.5.3 Historic and Forecasted Market Size by Segments
  9.5.4 Historic and Forecasted Market Size By Technique
  9.5.4.1 Sandwich Assays
  9.5.4.2 Competitive Assays
  9.5.4.3 Multiplex Detection Assays)
  9.5.4.4 Sample Type(Blood Samples
  9.5.4.5 Urine Samples
  9.5.4.6 Saliva Samples
  9.5.4.7 Others
  9.5.5 Historic and Forecasted Market Size By Type
  9.5.5.1 Kits & Reagents
  9.5.5.2 Lateral Flow Readers
  9.5.6 Historic and Forecasted Market Size By Application
  9.5.6.1 Clinical Testing
  9.5.6.2 Veterinary Diagnostics
  9.5.6.3 Food Safety & Environmental Testing
  9.5.6.4 Drug Development & Quality Testing
  9.5.7 Historic and Forecasted Market Size By End User
  9.5.7.1 Hospitals & Clinics
  9.5.7.2 Diagnostics Laboratories
  9.5.7.3 Home Care Settings
  9.5.7.4 Pharmaceuticals & Biotechnology Companies
  9.5.7.5 Others
  9.5.8 Historic and Forecast Market Size by Country
  9.5.8.1 China
  9.5.8.2 India
  9.5.8.3 Japan
  9.5.8.4 South Korea
  9.5.8.5 Malaysia
  9.5.8.6 Thailand
  9.5.8.7 Vietnam
  9.5.8.8 The Philippines
  9.5.8.9 Australia
  9.5.8.10 New Zealand
  9.5.8.11 Rest of APAC
 9.6. Middle East & Africa Lateral Flow Assay Market
  9.6.1 Key Market Trends, Growth Factors and Opportunities
  9.6.2 Top Key Companies
  9.6.3 Historic and Forecasted Market Size by Segments
  9.6.4 Historic and Forecasted Market Size By Technique
  9.6.4.1 Sandwich Assays
  9.6.4.2 Competitive Assays
  9.6.4.3 Multiplex Detection Assays)
  9.6.4.4 Sample Type(Blood Samples
  9.6.4.5 Urine Samples
  9.6.4.6 Saliva Samples
  9.6.4.7 Others
  9.6.5 Historic and Forecasted Market Size By Type
  9.6.5.1 Kits & Reagents
  9.6.5.2 Lateral Flow Readers
  9.6.6 Historic and Forecasted Market Size By Application
  9.6.6.1 Clinical Testing
  9.6.6.2 Veterinary Diagnostics
  9.6.6.3 Food Safety & Environmental Testing
  9.6.6.4 Drug Development & Quality Testing
  9.6.7 Historic and Forecasted Market Size By End User
  9.6.7.1 Hospitals & Clinics
  9.6.7.2 Diagnostics Laboratories
  9.6.7.3 Home Care Settings
  9.6.7.4 Pharmaceuticals & Biotechnology Companies
  9.6.7.5 Others
  9.6.8 Historic and Forecast Market Size by Country
  9.6.8.1 Turkiye
  9.6.8.2 Bahrain
  9.6.8.3 Kuwait
  9.6.8.4 Saudi Arabia
  9.6.8.5 Qatar
  9.6.8.6 UAE
  9.6.8.7 Israel
  9.6.8.8 South Africa
 9.7. South America Lateral Flow Assay Market
  9.7.1 Key Market Trends, Growth Factors and Opportunities
  9.7.2 Top Key Companies
  9.7.3 Historic and Forecasted Market Size by Segments
  9.7.4 Historic and Forecasted Market Size By Technique
  9.7.4.1 Sandwich Assays
  9.7.4.2 Competitive Assays
  9.7.4.3 Multiplex Detection Assays)
  9.7.4.4 Sample Type(Blood Samples
  9.7.4.5 Urine Samples
  9.7.4.6 Saliva Samples
  9.7.4.7 Others
  9.7.5 Historic and Forecasted Market Size By Type
  9.7.5.1 Kits & Reagents
  9.7.5.2 Lateral Flow Readers
  9.7.6 Historic and Forecasted Market Size By Application
  9.7.6.1 Clinical Testing
  9.7.6.2 Veterinary Diagnostics
  9.7.6.3 Food Safety & Environmental Testing
  9.7.6.4 Drug Development & Quality Testing
  9.7.7 Historic and Forecasted Market Size By End User
  9.7.7.1 Hospitals & Clinics
  9.7.7.2 Diagnostics Laboratories
  9.7.7.3 Home Care Settings
  9.7.7.4 Pharmaceuticals & Biotechnology Companies
  9.7.7.5 Others
  9.7.8 Historic and Forecast Market Size by Country
  9.7.8.1 Brazil
  9.7.8.2 Argentina
  9.7.8.3 Rest of SA

Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies

Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research
 

Lateral Flow Assay Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 5.8 Billion

Forecast Period 2024-32 CAGR:

4.90%

Market Size in 2032:

USD 29.82 Billion

 

By Type

  • Kits & Reagents
  • Lateral Flow Readers

Segments Covered:

By Technique

  • Sandwich Assays
  • Competitive Assays
  • Multiplex Detection Assays

By Sample Type

  • Blood Samples
  • Urine Samples
  • Saliva Samples

By Application

  • Clinical Testing
  • Veterinary Diagnostics
  • Food Safety & Environmental Testing
  • Drug Development & Quality Testing

By End User

  • Hospitals & Clinics
  • Diagnostics Laboratories
  • Home Care Settings
  • Pharmaceuticals & Biotechnology Companies
  • Others

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Technological Advancements

Key Market Restraints:

  • Competition from Alternative Testing Methods

Key Opportunities:

  • Expansion in Emerging Markets

Companies Covered in the report:

  • Abbott Laboratories (USA), Roche Diagnostics (Switzerland), Quidel Corporation (USA), Siemens Healthineers (Germany), BD (Becton, Dickinson and Company) (USA), bioMérieux (France), Hologic, Inc. (USA), Meridian Bioscience, Inc. (USA), PerkinElmer, Inc. (USA) and Other Active Players.

Frequently Asked Questions :

What would be the forecast period in the Lateral Flow Assay Market research report?
The forecast period in the Lateral Flow Assay Market research report is 2024-2032.
Who are the key players in the Lateral Flow Assay Market?
Abbott Laboratories (USA), Roche Diagnostics (Switzerland), Quidel Corporation (USA), Siemens Healthineers (Germany), BD (Becton, Dickinson and Company) (USA), bioMérieux (France), Hologic, Inc. (USA), Meridian Bioscience, Inc. (USA), PerkinElmer, Inc. (USA), Medline Industries, Inc. (USA), Danaher Corporation (USA), Agilent Technologies (USA), and Other Active Players.
What are the segments of the Lateral Flow Assay Market?
The Lateral Flow Assay Market is segmented into Technique, Sample Type, Type, Application, End User and region. By Technique, the market is categorized into Sandwich Assays, Competitive Assays, Multiplex Detection Assays. By Sample Type, the market is categorized into Blood Samples, Urine Samples, Saliva Samples, Others. By Type, the market is categorized into Kits & Reagents, Lateral Flow Readers. By Application, the market is categorized into Clinical Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, Drug Development & Quality Testing. By End User, the market is categorized into Hospitals & Clinics, Diagnostics Laboratories, Home Care Settings, Pharmaceuticals & Biotechnology Companies, Others. By region, it is analyzed across North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC), Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA).
What is the Lateral Flow Assay Market?
Lateral Flow Assay (LFA) market is defined as the field associated with the creation and supply of portable diagnostic devices that use lateral flow processes for the identification of target biomolecules, antibodies, or pathogens in assorted matrices. These assays have all become popular because they are easy to perform, fast and compact in size thus being indispensable in areas like clinical diagnosis, animal disease diagnosis, checking of food quality and inspection of the environment.
How big is the Lateral Flow Assay Market?
Lateral Flow Assay Market Size Was Valued at USD 5.8 Billion in 2023, and is Projected to Reach USD 29.82 Billion by 2032, Growing at a CAGR of 4.90% From 2024-2032.